Epidemiological study to characterize the prevalence and distribution of lipoprotein (a) levels among patients with established cardiovascular disease.

Epidemiological study to characterize the prevalence and distribution of lipoprotein (a) levels among patients with established cardiovascular disease.
Recruiting
18 years - 80 years
All
Phase N/A
1 Location

Brief description of study

The purpose of this study is to collect information about the blood level of a specific marker (lipoprotein (a)). Similar to other blood lipids, such as the "bad cholesterol", lipoprotein (a) levels were found to be associated with the risk of hardening of the arteries, known as atherosclerosis, which leads to conditions such as heart attacks, stroke, or peripheral artery disease (severe pain in legs while walking or lower limb amputation.) 

In this study which is performed on a global scale, we will collect information from patients with these conditions to better understand what the lipoprotein (a) levels are over a broad geography. 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: cardiovascular disease,heart attack,stroke,peripheral arterial disease,elevated lipoprotein (a)
  • Age: 18 years - 80 years
  • Gender: All

  • History of heart attack OR
  • History of stroke OR
  • Peripheral arterial disease

Updated on 19 Feb 2024. Study ID: 833997

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.